Fosbait 250mg Tablet
By Fosbait
Rx
30 Tablet in a Strip

Composition
Lanthanum Carbonate(250mg)

Manufacturer - Panacea Biotec Ltd
Ambala- Chandigarh Highway, Lalru – 140501, Punjab

Expires on or after
May, 2026

liver
Limited information is currently available regarding the use of Foschek 250mg Tablet in individuals with liver conditions. Due to this lack of data, it is essential to seek advice from your healthcare provider before using this medication if you have liver problems. Consulting your doctor will ensure the appropriate guidance and monitoring necessary for your specific situation.

kidney
Foschek 250mg Tablet is likely safe for patients with kidney disease. There's limited data that indicates adjusting the dose may not be necessary. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Foschek 250mg Tablet.

driving
Caution should be exercised when driving while taking Foschek 250mg Tablet as uncommon side effects like dizziness and vertigo may impair your ability to drive safely.

pregnancy
Caution is advised when using Foschek 250mg Tablet during pregnancy. Limited human studies suggest potential harm to the baby, based on animal research. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
Foschek 250mg Tablet is likely safe during breastfeeding based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Organic carbonic acid derivative |
Therapeutic Class | - |
Action Class | - |
₹408.5
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025